乳腺癌保乳术后脱细胞真皮基质重建的影像学监测
本研究纳入201例接受保乳术并即刻使用MegaDerm®(片型与颗粒型)重建的女性,术后共行713次乳腺X线、1063次超声和607次MRI检查。MegaDerm®在乳腺X线上呈边界清楚的等或高密度肿块,超声上伴后方声影,MRI上无强化。与MegaDerm®直接接触的可疑影像表现可能与假阳性或复发相关,作者认为识别这些特征性表现并在有疑问时回顾MegaDerm®植入史至关重要。
要点
- MegaDerm®在MG上呈边界清楚的等或高密度肿块,US上伴后方声影,MRI上无强化。
- 片型MegaDerm®钙化更常见且增大,颗粒型常表现为边缘不规则。
- 与MegaDerm®直接接触的可疑表现中,部分假阳性随访显示无变化或消退。
核心结论
- 与MegaDerm®直接接触的可疑影像表现可能与假阳性或复发相关,作者认为识别这些特征性表现并在有疑问时回顾MegaDerm®植入史至关重要。
研究设计与样本
- 本研究纳入201例女性(年龄范围28-81岁,平均年龄±标准差53.2±8.6岁),均接受保乳术并即刻使用MegaDerm®重建。
- 术后每例患者至少接受一次乳腺X线、超声和MRI检查,总计713次乳腺X线、1063次超声和607次MRI检查。
- 术后影像按MegaDerm®两种类型(片型和颗粒型)分别回顾,分析可疑影像表现(假阳性和复发),重点关注与MegaDerm®直接接触的表现。
关键影像表现/征象
- MegaDerm®在乳腺X线上表现为边界清楚的肿块,呈均匀等或高密度。
- MegaDerm®在超声上表现为后方声影。
- MegaDerm®在MRI上无强化。
- 片型MegaDerm®钙化更常见且尺寸增大,颗粒型常表现为边缘不规则。
- 常见可疑表现包括:乳腺X线上的钙化、不对称和MegaDerm®不规则;超声上的肿块和MegaDerm®不规则;MRI上的强化肿块和伴强化的MegaDerm®不规则。
诊断标准与关键数值
- 17例假阳性中9例在与MegaDerm®直接接触处有可疑表现,9例复发中6例有类似表现。
- 仅1例复发在乳腺X线和超声上观察到MegaDerm®不规则伴钙化。
- 在与MegaDerm®直接接触的假阳性中,44.4%(4/9)的可疑表现在随访中无变化或消退。
临床应用与阅片要点
- 作者认为识别与MegaDerm®相关的特征性影像表现(如钙化、不对称、不规则、肿块、强化)对判断假阳性或复发有帮助。
- 作者认为在有疑问时回顾患者MegaDerm®植入史至关重要。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study was to investigate postoperative imaging findings of patients who underwent breast-conserving surgery for cancer and reconstruction with MegaDerm® (sheet-type and pellet-type), analyzing false positives and recurrences, using multi-modality images.
MATERIALS AND METHODS: This study included 201 women (age range: 28-81 years, mean age ± standard deviation: 53.2 ± 8.6 years) who underwent breast-conserving surgery and immediate reconstruction with MegaDerm®. Post-surgery, each patient underwent at least one mammography (MG), ultrasonography (US), and MRI, totaling 713 MG, 1063 US, and 607 MRI examinations. Postoperative images were reviewed separately for the two types of MegaDerm®, and suspicious imaging findings (false positives and recurrences) were analyzed, with a particular focus on the findings in direct contact with MegaDerm®.
RESULTS: MegaDerm® appeared as a circumscribed mass with homogeneous iso- or high density on MG, posterior shadowing on US, and no enhancement on MRI. Calcification was more common and increased in size in sheet-type MegaDerm®, while pellet-type often exhibited irregular margins. Nine out of 17 false positives had suspicious findings in direct contact with MegaDerm®, and six out of nine recurrences showed similar findings. Common suspicious findings included calcifications, asymmetries, and MegaDerm® irregularities on MG; masses and MegaDerm® irregularities on US; and enhancing masses and MegaDerm® irregularities with enhancement on MRI. Notably, MegaDerm® irregularity with calcification was observed on MG and US in only one recurrence case. In 44.4% (4/9) of false-positives in direct contact with MegaDerm®, suspicious findings showed no change or resolution on follow-up.
CONCLUSION: Suspicious imaging findings in direct contact with MegaDerm® may be associated with false positives or recurrences. Therefore, it is essential to recognize these characteristic findings and review the patient's history of MegaDerm® insertion when in doubt.
引用
- Jung DW, Chung J, Kim JM, et al. Imaging Surveillance After Breast-Conserving Surgery for Cancer With Acellular Dermal Matrix Reconstruction. Korean J Radiol. 2024. PMID: 39473090. doi:10.3348/kjr.2023.1073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。